Contraceptive Drugs Market Size, Share, Growth Analysis, By Type (Oral Contraceptives, Combined Oral Contraceptive Pills), By Distribution (Hospital & Clinics, Retail Pharmacy), By Region - Industry Forecast 2025-2032

Contraceptive Drugs Market size was valued at USD 31946.38 Million in 2023 and is poised to grow from USD 34022.89 Million in 2024 to USD 56307.74 Million by 2032, growing at a CAGR of 6.50% during the forecast period (2025-2032).

Global contraceptive drugs market is highly competitive with the presence of local as well as global companies. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of global contraceptive drugs market. 'Pfizer Inc. (USA) ', 'Bayer AG (Germany) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Mylan N.V. (Netherlands) ', 'Novartis AG (Switzerland) ', 'Johnson & Johnson (USA) ', 'GlaxoSmithKline plc (UK) ', 'Allergan plc (Ireland) ', 'Agile Therapeutics, Inc. (USA) ', 'Piramal Healthcare (India) ', 'Organon & Co. (Netherlands) ', 'HRA Pharma (France) ', 'CooperSurgical, Inc. (USA) ', 'Church & Dwight Co., Inc. (USA) ', 'Merck & Co., Inc. (USA) ', 'Famy Care Ltd. (India) ', 'Sinopharm Group Co., Ltd. (China) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Torrent Pharmaceuticals Ltd. (India) ', 'Dr. Reddy's Laboratories Ltd. (India) ', 'In May 2022, NetVation DL Medicine announced research collaboration with Pfizer Inc. NetVation DL Medicine ("DL Medicine"), a privately held biotechnology business based in Chengdu, China that is focused on the discovery and development of innovative drug concepts, has established two-year research collaboration with Pfizer Inc.', 'In March 2022, Agile Therapeutics collaborated with award-winning director Maya Albanese on the first Twirl advertisement, Gen Z. Agile Therapeutics, Inc., a growing women's healthcare company, announced the release of its first consumer advertisement, Twirla Weekly Birth Control Patch Awareness.'

Poor and low-income populations are represented in the overall rate of unintended pregnancy worldwide. One of the primary factors contributing to this prevalence is the use of traditional methods to prevent pregnancy. Also, unsafe abortions and maternal deaths occur every year. In Latin America, teenagers under the age of 16 have a four-time increase in the risk of maternal death compared to women in their thirties. So, the use of contraceptive drugs contributes significantly to the decrease in unplanned pregnancies.

Technological advancement is an ongoing trend gaining popularity in the contraceptive drugs market. Digital contraception is the latest trend in the market. Digital contraception is a way to track periods online to know which days are at risk for pregnancy. In March 2021, Berlin-based femtech company Clu received FDA approval to market Clu Birth Control, an all-digital contraceptive based on period monitoring data. The contraceptive function can combine a user's menstrual cycle data with Clue's prediction algorithm to identify when there is a high or low risk for pregnancy. Users can then adjust their habits to their risk tolerance. Clue recommends that users refrain from intercourse altogether or use another form of contraception, such as condoms, on high-risk days.

On the basis of region, global contraceptive drugs market is divided into North America, Europe, Asia Pacific and MEA. North America dominated global market in 2022, due to the high incidence of abortion, rising population of women within the age group of 15-44 years, and high patient awareness levels in this region. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives in teenagers. The U.S. is dominating the contraceptive drugs market in North America. The increased awareness of contraceptive pills among patients is driving the growth of the market in North America.